Skip to main content
Clinical Trials/IRCT2015110624903N1
IRCT2015110624903N1
Completed
Phase 4

investigation of the effectiveness of combination of losartan with Rocaltrol on treatment of albuminuria in patient with diabetic nephropathy; a clinical trial.

Arak University of Medical Sciences0 sites132 target enrollmentTBD

Overview

Phase
Phase 4
Intervention
Not specified
Conditions
diabetic nephropathy.
Sponsor
Arak University of Medical Sciences
Enrollment
132
Status
Completed
Last Updated
8 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
8 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • aged between 40\-70 years; diabetes mellitus type 2 that at least 3 months past diagnosis; Albuminuria is (urinary albumin \>30 mg/24 hours); Signing Informed consent form; ca \<9\.5 and p \<5\.5; Not having an active urine analysis regarding Hematuria, pyuria and urine cast or crystal.
  • Exclusion criteria: K \> 5\.5 mg per deciliter or creatinine rising more than 30% after administration of Losartan; administration of vitamin D agents; acute infectious disease; acute heart failure; cancer; pregnancy; Urinary protein more than 8 gr/24 hours; vitamin D deficiency.

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Not specified

Similar Trials